0.1200
0.0000
(0.00%)
At close: January 7 at 11:43:11 AM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-393.1790
-464.8570
-1,177.7790
-740.2600
-69.0560
Financing Cash Flow
--
--
2,997.3510
874.7050
104.3330
End Cash Position
968.2930
1,363.5770
1,795.6300
179.8340
45.3890
Issuance of Capital Stock
--
--
2,997.3510
874.7050
3.3330
Issuance of Debt
--
--
--
--
101.0000
Free Cash Flow
-393.1790
-464.8570
-1,177.7790
-740.2600
-69.0560
12/31/2020 - 3/30/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ILA.AX Island Pharmaceuticals Limited
0.1650
-5.71%
TYP.AX TRYPTAMINE FPO [TYP]
0.0370
-5.13%
WBIO.CN WPD Pharmaceuticals Inc.
0.1900
0.00%
RAC.AX Race Oncology Limited
1.2800
-0.78%
DOSE.CN Rapid Dose Therapeutics Corp.
0.2250
-6.25%
CHGX.CN ChitogenX Inc.
0.0250
+66.67%
BLAB.CN Britannia Life Sciences Inc.
0.0850
0.00%
AGN.CN Algernon Pharmaceuticals Inc.
0.0850
0.00%
BCAX Bicara Therapeutics Inc.
14.38
-5.70%
BCTX BriaCell Therapeutics Corp.
0.4028
-6.74%